Key facts
- This page summarizes Mark R. Lanning's Form 4 filing for AtriCure, Inc. (ATRC).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 May 2021, 08:07.
Mark R. Lanning - 05 May 2021 Form 4 Insider Report for AtriCure, Inc. (ATRC)
- Reporting relationship
- Director
- Issuer ticker
- ATRC
- Reported as of
- 05 May 2021
- Net transaction value
- +$141,700
- Reporting owner signature
- /s/ Mark R. Lanning
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Mark R. Lanning filed Form 4 for AtriCure, Inc. (ATRC) on 07 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$141,700.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATRC
transaction
Common Stock
Options Exercise
- Transaction value
- $141,700
- Shares
- +10,000
- Change %
- +7.6%
- Price
- $14.17
- Shares after
- 140,886
- Date
- 05 May 2021
- Ownership
- Direct
ATRC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,800
- Date
- 05 May 2021
- Ownership
- Held by spouse
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATRC
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -10,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $14.17
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
Footnote F2
These options were granted on May 18, 2011 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant.